SCHEDULE 13G/A: T. Rowe Price Associates Discloses 15.3% Stake in CI&T INC/UNITED STATES-A

T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a 15.3% beneficial ownership stake in CI&T INC/UNITED STATES-A as of March 31, 2025.

Summary

• T. Rowe Price Associates, Inc. reported beneficial ownership of 3,443,533 shares of CI&T INC/UNITED STATES-A common stock.
• This ownership represents 15.3% of the total class of securities.
• The filing indicates T. Rowe Price Associates, Inc. holds sole voting power over 3,439,251 shares and sole dispositive power over 3,443,533 shares.
• No shared voting or dispositive power was reported.
• A significant portion of the reported shares, specifically 2,679,241 shares (representing 11.9% of the class), are held by T. ROWE PRICE INTERNATIONAL DISCOVERY FUND, for which T. Rowe Price Associates, Inc. serves as the investment adviser.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The disclosure of a significant stake by a major institutional investor like T. Rowe Price Associates, Inc. can be viewed positively by the market, indicating confidence in the issuer.

Positives

• The disclosure of a significant 15.3% stake by T. Rowe Price Associates, Inc., a major institutional investment adviser, can signal strong institutional confidence in CI&T INC/UNITED STATES-A.
• A substantial portion of the stake (11.9%) is held by T. ROWE PRICE INTERNATIONAL DISCOVERY FUND, indicating a dedicated and potentially long-term investment by a specific fund.
• The filing explicitly states that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control, which may alleviate concerns about potential activist investor actions or hostile takeovers.

Stakeholder Impact

• Shareholders: May view the significant institutional ownership as a positive signal of confidence in the company's prospects and stability.

Key Dates

Keywords

CI&T INC, T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Adviser, G21307106